OBJECTIVE: Although the incidence of stroke after carotid endarterectomy (CEA) is low (1-3%), approximately 25% of patients experience subtle declines in postoperative neuropsychometric function. No studies have investigated the risk factors for this neurocognitive change. We sought to identify predictors of postoperative neurocognitive dysfunction. METHODS: We enrolled 186 CEA patients, with both symptomatic and asymptomatic stenosis, to undergo a battery of neuropsychometric tests preoperatively and on postoperative Days 1 and 30. Neurocognitive dysfunction was defined as a two standard deviation decline in performance compared with a similarly aged control group of lumbar laminectomy patients. Univariate logistic regression was performed for age, sex, obesity, smoking, symptomatology, diabetes mellitus, hypertension, hypercholesterolemia, use of statin medication, previous myocardial infarction, previous CEA, operative side, duration of surgery, duration of carotid cross-clamp, and weight-adjusted doses of midazolam and fentanyl. Variables achieving univariate P < 0.10 were included in a multivariate analysis. Data is presented as (odds ratio, 95% confidence interval, P-value). RESULTS: Eighteen and 9% of CEA patients were injured on postoperative Days 1 and 30, respectively. Advanced age predicted neurocognitive dysfunction on Days 1 and 30 (1.93 per decade, 1.15-3.25, 0.01; and 2.57 per decade, 1.01-6.51, 0.049, respectively). Additionally, diabetes independently predicted injury on Day 30 (4.26, 1.15-15.79, 0.03). CONCLUSIONS: Advanced age and diabetes predispose to neurocognitive dysfunction after CEA. These results are consistent with risk factors for neurocognitive dysfunction after coronary bypass and major stroke after CEA, supporting an underlying ischemic pathophysiology. Further work is necessary to determine the role these neurocognitive deficits may play in appropriately selecting patients for CEA.
OBJECTIVE: Although the incidence of stroke after carotid endarterectomy (CEA) is low (1-3%), approximately 25% of patients experience subtle declines in postoperative neuropsychometric function. No studies have investigated the risk factors for this neurocognitive change. We sought to identify predictors of postoperative neurocognitive dysfunction. METHODS: We enrolled 186 CEA patients, with both symptomatic and asymptomatic stenosis, to undergo a battery of neuropsychometric tests preoperatively and on postoperative Days 1 and 30. Neurocognitive dysfunction was defined as a two standard deviation decline in performance compared with a similarly aged control group of lumbar laminectomy patients. Univariate logistic regression was performed for age, sex, obesity, smoking, symptomatology, diabetes mellitus, hypertension, hypercholesterolemia, use of statin medication, previous myocardial infarction, previous CEA, operative side, duration of surgery, duration of carotid cross-clamp, and weight-adjusted doses of midazolam and fentanyl. Variables achieving univariate P < 0.10 were included in a multivariate analysis. Data is presented as (odds ratio, 95% confidence interval, P-value). RESULTS: Eighteen and 9% of CEA patients were injured on postoperative Days 1 and 30, respectively. Advanced age predicted neurocognitive dysfunction on Days 1 and 30 (1.93 per decade, 1.15-3.25, 0.01; and 2.57 per decade, 1.01-6.51, 0.049, respectively). Additionally, diabetes independently predicted injury on Day 30 (4.26, 1.15-15.79, 0.03). CONCLUSIONS: Advanced age and diabetes predispose to neurocognitive dysfunction after CEA. These results are consistent with risk factors for neurocognitive dysfunction after coronary bypass and major stroke after CEA, supporting an underlying ischemic pathophysiology. Further work is necessary to determine the role these neurocognitive deficits may play in appropriately selecting patients for CEA.
Authors: M F Newman; N D Croughwell; J A Blumenthal; E Lowry; W D White; W Spillane; R D Davis; D D Glower; L R Smith; E P Mahanna Journal: Ann Thorac Surg Date: 1995-05 Impact factor: 4.330
Authors: M E Gaunt; P J Martin; J L Smith; T Rimmer; G Cherryman; D A Ratliff; P R Bell; A R Naylor Journal: Br J Surg Date: 1994-10 Impact factor: 6.939
Authors: H J M Barnett; D W Taylor; R B Haynes; D L Sackett; S J Peerless; G G Ferguson; A J Fox; R N Rankin; V C Hachinski; D O Wiebers; M Eliasziw Journal: N Engl J Med Date: 1991-08-15 Impact factor: 91.245
Authors: M F Newman; N D Croughwell; J A Blumenthal; W D White; J B Lewis; L R Smith; P Frasco; E A Towner; R M Schell; B J Hurwitz Journal: Circulation Date: 1994-11 Impact factor: 29.690
Authors: Mary C Zuniga; Thuy B Tran; Brittanie D Baughman; Gayatri Raghuraman; Elizabeth Hitchner; Allyson Rosen; Wei Zhou Journal: Ann Surg Date: 2016-10 Impact factor: 12.969
Authors: Gene T Yocum; John G Gaudet; Susie S Lee; Yaakov Stern; Lauren A Teverbaugh; Robert R Sciacca; Charles W Emala; Donald O Quest; Paul C McCormick; James F McKinsey; Nicholas J Morrissey; Robert A Solomon; E Sander Connolly; Eric J Heyer Journal: Stroke Date: 2009-03-12 Impact factor: 7.914
Authors: José R Romero; Alexa Beiser; Sudha Seshadri; Emelia J Benjamin; Joseph F Polak; Ramachandran S Vasan; Rhoda Au; Charles DeCarli; Philip A Wolf Journal: Stroke Date: 2009-03-05 Impact factor: 7.914
Authors: Eric J Heyer; Joanna L Mergeche; Zirka H Anastasian; Minjae Kim; Kaitlin A Mallon; E Sander Connolly Journal: Neurosurgery Date: 2014-03 Impact factor: 4.654
Authors: A S Turk; I Chaudry; V M Haughton; B P Hermann; H A Rowley; K Pulfer; B Aagaard-Kienitz; D B Niemann; P A Turski; R L Levine; C M Strother Journal: AJNR Am J Neuroradiol Date: 2007-11-07 Impact factor: 3.825